While searching for brca 1 and 2, it could possibly have sought a method patent, but the processes used were well understood by geneticists at the time of myriad's patents, well understood, widely used, fairly uniform insofar as any scientist engaged in the search for a gene would likely have utilized a similar approach. so the question of course is what myriad's got here right now. and we're looking to them for answers. i did see an e-mail that their stock was up. >> hold that thought. i want to bring in jeffrey toobin, our senior analyst. people were perplexed by this in so many ways if they...